Viewing Study NCT04498169


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2026-05-16 @ 5:40 PM
Study NCT ID: NCT04498169
Status: COMPLETED
Last Update Posted: 2022-09-15
First Post: 2020-07-31
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy
Sponsor: Aerie Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Corneal Edema View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Corneal Edema View
None Fuchs Corneal Dystrophy View
None Netarsudil Ophthalmic Solution View